Logo Loading...

Phone: +91 7499180452

Mail: sales@mindsinsights.com

Logo

Opioid Use Disorder Market by Size, Share, Types (Bunavail, Sublocade, Suboxone, Zubsolv), Applications (Moderate Pain Treatment, Severe Pain Treatment) and Forecasts by 2027

Global Opioid Use Disorder market was valued at around USD 2.52 billion in 2020 and is expected to grow with the CAGR of 10.2% during forecast period 2021-2027.

Nowadays a business needs to move at the speed of their consumers. Keep a track of consumer needs and perspectives, and respond to market trends, to generate profitable business while using the right solutions at the right time.

Opioid Use Disorder Industry Report Scope 
The research study focuses on enhancing the basic knowledge of the market professionals about the main product/service, by explicating details like definition, its uses and applications, industry segmentation as well as a global industry outlook. The report further helps in making sound investment decision by listing factors that will contribute to the growth of market worldwide. The study also details about the foreign trade of the product along with the list of major importing and top exporting countries. The research study will also help understand graphical representation and forecasts of key data. 

Market Segmentation
Minds Insights provides an analysis of the key trends in each segment of the Opioid Use Disorder-market report, along with forecasts for growth at the region, country and global level from 2021-2027. Our report has categorized the market based on type, application and region.

On the basis of the Type:

  • Bunavail
  • Sublocade
  • Suboxone
  • Zubsolv
  • Others

On the basis of the Application:

  • Moderate Pain Treatment
  • Severe Pain Treatment

Important regions covered: 

  • North America: USA | Canada
  • Europe: UK | Germany | France |Spain | Italy | Russia | Netherlands | Belgium | Switzerland | Rest of Europe
  • Asia-Pacific: China | Japan | India |South Korea | Australia | Indonesia | Thailand | Philippines | Vietnam | Rest of Asia-Pacific
  • LAMEA: Brazil| Mexico | Argentina | Colombia | Chile | Peru | Rest of LAMEA
  • Middle East: Turkey | Saudi Arabia | United Arab Emirates| South Africa| Israel | Egypt |Nigeria | Rest of Middle East
     

Competitive Analysis
The report also includes key company profiles in Opioid Use Disorder Industry with their market strategies and SWOT analysis. The report focuses on the industry’s main competitors with information such as business profiles, components and financial information of the past 5 years, and key developments. The competitive landscape of the industry has been examined along with the profiles of the key players: 

  • Camurus
  • Pfizer Inc.
  • BioDelivery Sciences International Inc.
  • TEVA PHARMACEUTICALS USA, INC
  • Orexo US, Inc.
  • Indivior PLC
  • Hikma Pharmaceuticals
  • Mylan
  • Mallinckrodt.
  • Titan Pharmaceuticals Inc.
  • Alkermes


The report describes prominent players in the Opioid Use Disorder market segment along with their basic profile, company information and recent developments. The report includes crucial information like manufacturing process, raw material requirements and supply-demand side. For investors, and new ventures the report includes information such as costs involved, revenue, market share and size, growth prospects involved.

Major factors covered in this report

  • Market Dynamics: Market Drivers and Restraints
  • Value-Chain: Supply and Demand Analysis
  • Cost and Price Structure Analysis
  • Competitive Analysis
  • Porter’s Five Forces Analysis
     

What will the report include?

  • Highlights of main global R&D activities and new technological developments
  • Estimation of the actual market size and revenue forecasts for global market
  • Description of the most relevant research and development activities related to Opioid Use Disorder market places
  • Production of Opioid Use Disorder, and review of application for Opioid Use Disorder and assessment of emerging applications
  • Analyses of the global market trends, with data from 2020, estimates for 2021, and forecast through 2027
  • Review of current industry players, including manufacturers of Opioid Use Disorder, technology developments, and future market participants
     

Some of the key questions addressed in the report were…

  • What were the market size in 2014 and the outlook from 2021 to 2027?
  • How much growth will the industry market experience between 2017 and 2027?
  • What are the important factors, constraints, and opportunities, and how they will affect market?
  • What are the key segments of the Opioid Use Disorder market growth and why?
  • Who are the main participants and strategies they use to compete in the market?
     

Our reports are comprised of thorough analysis which includes business scientific analysis, data engineering, behavioural analysis experts and data strategy statistics based in 15 markets around the world. We use data and intelligence to help our clients build long-term relationship with their consumer.

  • Minds Insights is the foundation for data driven insights in various industry verticals using four key capabilities:
    Qualitative Research
    Quantitative Research
    Strategy Building
    Research Design

1          Introduction

  • Research Scope
  • Research Methodology and Assumptions
  • Market Segmentation
  • Definitions

2          Executive Summary

3          Market Overview

  • Market Segmentation & Scope
  • Value Chain Analysis
  • Supply Chain Analysis
  • Porter’s Five Forces Analysis
  • Regulatory Landscape
  • Macro-Economic Indicators
  • Cost Structure Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Market Evaluation

4          Impact of COVID-19 on the Market

5          Technological Analysis

  • Technology advances
  • Upcoming Technology Landscape

6          Competitive Analysis

  • Market Share Analysis
  • Potential Venture Analysis
  • Key Winning Strategies

7          Pricing Analysis

  • Regional Price Analysis
  • Raw Material Analysis

8          Opioid Use Disorder Market, By Type Overview

  • BUNAVAIL
  • SUBLOCADE
  • SUBOXONE

9          Opioid Use Disorder Market, By Applications Overview

  • MODERATE PAIN TREATMENT
  • SEVERE PAIN TREATMENT
  • OTHERS

10        Regional Overview

  • Overview
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
  • Rest of the World
  • Latin America
  • Middle East and Africa

11        Competitive Landscape (Manufacturers & Suppliers)

INTRODUCTION (Business Overview, Platform, Solutions & Services, Key Insights, Recent Developments, SWOT Analysis)

  • CAMURUS.
  • PFIZER INC.
  • BIODELIVERY SCIENCES INTERNATIONAL INC.
  • TEVA PHARMACEUTICALS USA, INC
  • OREXO US, INC.
  • INDIVIOR PLC
  • HIKMA PHARMACEUTICALS
  • MYLAN
  • MALLINCKRODT.
  • TITAN PHARMACEUTICALS INC.

12        Conclusion & Recommendation

13        Analyst Review

14        Research Methodology

List of Figures

Fig.1      Product Picture of Opioid Use Disorder

Fig.2      Global Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.3      Global Opioid Use Disorder Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)

Fig.4      Global Opioid Use Disorder Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)

Fig.5      COVID-19 Impacts on Opioid Use Disorder Market

Fig.6      COVID-19 Impact on the Players

Fig.7      Business Strategies and Recommendations

Fig.8      Global Opioid Use Disorder Market Share, By Type, 2019 & 2026 (USD Million)

Fig.9      Global BUNAVAIL Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.10    Global SUBLOCADE Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.11    Global SUBOXONE Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.12    Global Opioid Use Disorder Market Share, By Application, 2019 & 2026 (USD Million)

Fig.13    Global MODERATE PAIN TREATMENT Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.14    Global SEVERE PAIN TREATMENT Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.15    Global OTHERS Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.16    Global Opioid Use Disorder Market Share, by Region, 2019 & 2026 (USD Million)

Fig.17    North America Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.18    U.S. Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.19    Canada Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.20    Europe Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.21    Germany Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.22    France Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.23    U.K. Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.24    Italy Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.25    Spain Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.26    Portugal Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.27    Cyprus Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.28    Lithuania Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.29    Greece Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.30    Rest of Europe Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.31    Asia Pacific Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.32    China Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.33    Japan Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.34    India Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.35    South  Korea Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.36    Rest of Asia Pacific Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.37    Latin America Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.38    Brazil Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.39    Mexico Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.40    Rest of Latin America Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.41    The Middle-East and Africa Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.42    GCC Countries Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.43    South Africa Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.44    Rest of Middle-East Africa Opioid Use Disorder Market, 2016 – 2026 (USD Million)

Fig.45    Competitor Market Share – Revenue

Fig.46    CAMURUS. Revenue and Growth Rate

Fig.47    CAMURUS. Market Share

Fig.48    PFIZER INC. Revenue and Growth Rate

Fig.49    PFIZER INC. Market Share

Fig.50    BIODELIVERY SCIENCES INTERNATIONAL INC. Revenue and Growth Rate

Fig.51    BIODELIVERY SCIENCES INTERNATIONAL INC. Market Share

Fig.51    TEVA PHARMACEUTICALS USA, INC Revenue and Growth Rate

Fig.52    TEVA PHARMACEUTICALS USA, INC Market Share

Fig.53    OREXO US, INC. Revenue and Growth Rate

Fig.54    INDIVIOR PLC Market Share

Fig.55    HIKMA PHARMACEUTICALS Revenue and Growth Rate

Fig.56    HIKMA PHARMACEUTICALS Market Share

Fig.57    MYLAN Revenue and Growth Rate

Fig.58    MYLAN Market Share

Fig.59    MALLINCKRODT. Revenue and Growth Rate

Fig.60    MALLINCKRODT. Market Share

Fig.59    TITAN PHARMACEUTICALS INC. Revenue and Growth Rate

Fig.60    TITAN PHARMACEUTICALS INC. Market Share

Fig.61    Global Opioid Use Disorder Market – Value Chain Analysis

Fig.62    Technology Roadmap and Timeline

Fig.63    Market Attractiveness Analysis – By Installation

Fig.64    Market Attractiveness Analysis – By Application

Fig.65    Market Attractiveness Analysis – By Region

 

List of Tables

Table 1  Global Opioid Use Disorder Market, 2019 & 2026 (USD Million)

Table 2  Global Opioid Use Disorder Market, By Type, 2016 – 2026 (USD Million)

Table 3  Global Opioid Use Disorder Market, By Installation, 2016 – 2026 (USD Million)

Table 4  Global Opioid Use Disorder Market, By Application, 2016 – 2026 (USD Million)

Table 5  Global Opioid Use Disorder Market, by Region, 2016 – 2026 (USD Million)

Table 6  North America Opioid Use Disorder Market, by Country, 2016 – 2026 (USD Million)

Table 7  North America Opioid Use Disorder Market, By Type, 2016 – 2026 (USD Million)

Table 8  North America Opioid Use Disorder Market, By Installation, 2016 – 2026 (USD Million)

Table 9  North America Opioid Use Disorder Market, By Application, 2016 – 2026 (USD Million)

Table 10 Europe Opioid Use Disorder Market, by Country, 2016 – 2026 (USD Million)

Table 11 Europe Opioid Use Disorder Market, By Type, 2016 – 2026 (USD Million)

Table 12 Europe Opioid Use Disorder Market, By Installation, 2016 – 2026 (USD Million)

Table 13 Europe Opioid Use Disorder Market, By Application, 2016 – 2026 (USD Million)

Table 14 Asia Pacific Opioid Use Disorder Market, by Country, 2016 – 2026 (USD Million)

Table 15 Asia Pacific Opioid Use Disorder Market, By Type, 2016 – 2026 (USD Million)

Table 16 Asia Pacific Opioid Use Disorder Market, By Installation, 2016 – 2026 (USD Million)

Table 17 Asia Pacific Opioid Use Disorder Market, By Application, 2016 – 2026 (USD Million)

Table 18 Latin America Opioid Use Disorder Market, by Country, 2016 – 2026 (USD Million)

Table 19 Latin America Opioid Use Disorder Market, By Type, 2016 – 2026 (USD Million)

Table 20 Latin America Opioid Use Disorder Market, By Installation, 2016 – 2026 (USD Million)

Table 21 Latin America Opioid Use Disorder Market, By Application, 2016 – 2026 (USD Million)

Table 22 The Middle-East and Africa Opioid Use Disorder Market, by Country, 2016 – 2026 (USD Million)

Table 23 The Middle-East and Africa Opioid Use Disorder Market, By Type, 2016 – 2026 (USD Million)

Table 24 The Middle-East and Africa Opioid Use Disorder Market, By Installation, 2016 – 2026 (USD Million)

Table 25 The Middle-East and Africa Opioid Use Disorder Market, By Application, 2016 – 2026 (USD Million)

Table 26 Global Opioid Use Disorder Market - Company Revenue Analysis, 2016 – 2019 (USD Million)

Table 27 Global Opioid Use Disorder Market - Company Revenue Share Analysis, 2016 – 2019 (%)

Table 28 Acquisitions and Mergers

Table 29 Market Drivers – Impact Analysis

Table 30 Market Restraints

Table 31 Market Opportunities